Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Sci Total Environ ; 859(Pt 1): 160172, 2022 Nov 15.
Article in English | MEDLINE | ID: covidwho-2232775

ABSTRACT

Unexpected outbreak of the 2019 novel coronavirus (COVID-19) has profoundly altered the way of human life and production activity, which posed visible impacts on PM2.5 and its chemical species. The abruptly emergency reduction in human activities provided an opportunity to explore the synergetic impacts of multi-factors on shaping PM2.5 pollution. Here, we conducted two comprehensive observation measurements of PM2.5 and its chemical species from 1 January to 16 February in Beijing 2020 and the same lunar date in 2021, to investigate temporal variations and reveal the driving factors of haze before and after Chinese New Year (CNY). Results show that mean PM2.5 concentrations during the whole observation were 63.83 and 66.86 µg/m3 in 2020 and 2021, respectively. Higher secondary inorganic species were observed after CNY, and K+, Cl- showed three prominent peaks which associated closely with fireworks burnings from suburb Beijing and surroundings, verifying that they could be used as two representative tracers of fireworks. Further, we explored the impacts of meteorological conditions, regional transportation as well as chemical reactions on PM2.5. We found that unfavorable meteorological conditions accounted for 11.0 % and 16.9 % of PM2.5 during CNY holidays in 2020 and 2021, respectively. Regional transport from southwest and southeast (south) played an important role on PM2.5 during the two observation periods. Higher ratio of NO3-/SO42- were observed under high OX and low RH conditions, suggesting the major pathway of NO3- and SO42- formation could be photochemical process and aqueous-phase reaction. Additionally, nocturnal chemistry facilitated the formation of secondary components of both inorganic and organic. This study promotes understandings of PM2.5 pollution in winter under the influence of COVID-19 pandemic and provides a well reference for haze and PM2.5 control in future.

2.
J Med Internet Res ; 24(2): e27704, 2022 02 16.
Article in English | MEDLINE | ID: covidwho-1690536

ABSTRACT

BACKGROUND: The COVID-19 pandemic has increased online purchases and heightened interest in existing treatments. Dexamethasone, hydroxychloroquine, and lopinavir-ritonavir have been touted as potential COVID-19 treatments. OBJECTIVE: This study assessed the availability of 3 potential COVID-19 treatments online and evaluated the safety and marketing characteristics of websites selling these products during the pandemic. METHODS: A cross-sectional study was conducted in the months of June 2020 to August 2020, by searching the first 100 results on Google, Bing, and Yahoo! mimicking a US consumer. Unique websites were included if they sold targeted medicines, were in English, offered US shipping, and were free to access. Identified online pharmacies were categorized as rogue, unclassified, or legitimate based on LegitScript classifications. Patient safety characteristics, marketing techniques, price, legitimacy, IP addresses, and COVID-19 mentions were recorded. RESULTS: We found 117 websites: 30 selling dexamethasone (19/30, 63% rogue), 39 selling hydroxychloroquine (22/39, 56% rogue), and 48 selling lopinavir-ritonavir (33/48, 69% rogue). This included 89 unique online pharmacies: 70% were rogue (n=62), 22% were unapproved (n=20), and 8% were considered legitimate (n=7). Prescriptions were not required among 100% (19/19), 61% (20/33), and 50% (11/22) of rogue websites selling dexamethasone, lopinavir-ritonavir, and hydroxychloroquine, respectively. Overall, only 32% (24/74) of rogue websites required prescriptions to buy these medications compared with 94% (31/33) of unapproved and 100% (10/10) of legitimate websites (P<.001). Rogue sites rarely offered pharmacist counseling (1/33, 3% for lopinavir-ritonavir to 2/22, 9% for hydroxychloroquine). Drug warnings were unavailable in 86% (6/7) of unapproved dexamethasone sites. It was difficult to distinguish between rogue, unapproved, and legitimate online pharmacies solely based on website marketing characteristics. Illegitimate pharmacies were more likely to offer bulk discounts and claim price discounts, yet dexamethasone and hydroxychloroquine were more expensive online. An inexpensive generic version of lopinavir-ritonavir that is not authorized for use in the United States was available online offering US shipping. Some websites claimed hydroxychloroquine and lopinavir-ritonavir were effective COVID-19 treatments despite lack of scientific evidence. In comparing IP addresses to locations claimed on the websites, only 8.5% (7/82) matched their claimed locations. CONCLUSIONS: The lack of safety measures by illegitimate online pharmacies endanger patients, facilitating access to medications without appropriate oversight by health care providers to monitor clinical response, drug interactions, and adverse effects. We demonstrated how easy it is to go online to buy medications that are touted to treat COVID-19 even when current clinical evidence does not support their use for self-treatment. We documented that illegitimate online pharmacies sidestep prescription requirements, skirt pharmacist counseling, and make false claims regarding efficacy for COVID-19 treatment. Health care professionals must urgently educate the public of the dangers of purchasing drugs from illegitimate websites and highlight the importance of seeking treatment through authentic avenues of care.


Subject(s)
Antiviral Agents , COVID-19 Drug Treatment , Commerce , Drug and Narcotic Control , Internet , Antiviral Agents/economics , Antiviral Agents/standards , Cross-Sectional Studies , Humans , Marketing , Pandemics , Prescriptions , SARS-CoV-2 , United States
3.
Carbohydr Polym ; 280: 119006, 2022 Mar 15.
Article in English | MEDLINE | ID: covidwho-1588175

ABSTRACT

Caulerpa lentillifera (Bryopsidophyceae, Chlorophyta) is an edible seaweed attracting great attention for its expansion of farming scale and increasing consumption in these years. In the present study, a sulfated polysaccharide (CLSP-2) was isolated and separated from C. lentillifera, and its chemical structure was elucidated by a series of chemical and spectroscopic methods. Among these methods, mild acid hydrolysis and photocatalytic degradation were applied to release mono- and oligo-saccharide fragments which were further identified by HPLC-MSn analysis, affording the information of the sugar sequences and the sulfate substitution in CLSP-2. Results indicated that the backbone of CLSP-2 was constructed of →6)-ß-Manp-(1→ with sulfated branches at C2, which were comprised of prevalent →3)-ß-Galp4S-(1→, →3)-ß-Galp2,4S-(1→, and minor Xyl. In addition, the virus neutralization assay revealed that CLSP-2 could effectively protect HeLa cells against SARS-CoV-2 infection with an IC50 of 48.48 µg/mL. Hence, the present study suggests CLSP-2 as a promising agent against SARS-CoV-2.


Subject(s)
COVID-19/virology , Caulerpa/chemistry , Polysaccharides/chemistry , Polysaccharides/pharmacology , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Chromatography, High Pressure Liquid/methods , HeLa Cells , Humans , Hydrolysis , Magnetic Resonance Spectroscopy/methods , Mass Spectrometry/methods , Molecular Weight , Polysaccharides/analysis , SARS-CoV-2 , Seaweed/chemistry , Spectroscopy, Fourier Transform Infrared/methods , Sulfates/chemistry
4.
Computers & Industrial Engineering ; : 107895, 2021.
Article in English | ScienceDirect | ID: covidwho-1578723

ABSTRACT

During cross-regional epidemic outbreaks, patients with suspected infection have a high demand for testing resources, while patients with confirmed infection have a high demand for treatment resources. The allocation of testing resources affects the demand for treatment resources in multiple regions and at different periods, which features a time-lag correlation. In this study, we developed a joint allocation model for allocating testing and treatment resources with consideration of their time-lag correlation to minimize the loss of patients and maximum the fairness of allocation in all regions. We devised a sequential solution generation strategy (SSGS) and combined it with the NSGA2 and MOPSO algorithms to solve the proposed joint allocation problem. We demonstrated numerically that NSGA2 coupled with SSGS yields a better solution. Furthermore, we compared the solutions of our joint allocation model with those of an independent allocation model. Our numerical results show that the joint allocation scheme, which considers the time-lag correlation between the two types of resources, has better performance—with a lower loss of patients and higher fairness of allocation. In particular, when the impact of the allocation of testing resources on the demand for treatment resources was increased, the joint allocation scheme performed better in terms of both the objectives.

SELECTION OF CITATIONS
SEARCH DETAIL